Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cholera Haemolysin Antibody (2024/251) - BSA Free, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$206.00 - $499.50

Specifications

Antigen Cholera Haemolysin
Clone 2024/251
Concentration 3.1 mg/mL
Dilution ELISA 1:100-1:2000
Applications ELISA
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NB017477
SDP
View Documents
Novus Biologicals
NB100624600.025MG
0.025 mg
Each for $206.00
Only null left
Add to Cart
 
NB10062460
SDP
View Documents
Novus Biologicals
NB10062460
0.1 mg
Each for $499.50
Only null left
Add to Cart
 
Description

Description

Cholera Haemolysin Monoclonal specifically detects Cholera Haemolysin in Bacteria samples. It is validated for ELISA.
Specifications

Specifications

Cholera Haemolysin
3.1 mg/mL
ELISA
Unconjugated
Mouse
Bacteria
IgG1
Protein A purified
NB100-62460 is specific for Vibrio cholerae haemolysin (HlyA). HlyA is an extracellular matrix damaging protein with a molecular weight of 65 kDa that exists a water-soluble monomer and an oligomeric amphipathic protein. It belongs to a class of proteins known as pore-forming toxins for their ability to punch holes in plasma membranes.
2024/251
ELISA 1:100-1:2000
Monoclonal
Purified
RUO
Native organisms
Primary
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Videos
SDS
Documents

Documents

Product Certifications

For Research Use Only

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.